In the news | 20th Aug 2021
Three Reasons Biopharma Companies Can’t Afford to Miss the Digital Revolution
Industry expert, Claire Hill, comments on the top three reasons biopharma companies simply can’t afford to wait any longer to join the digital revolution.
In the biopharmaceutical industry, there’s no shortage of data—the issue organizations more often face is how to capture data in ways that derive insight from it. As more and more companies are now recognizing, a fundamentally different approach is needed to realize the strategic benefits of data in making exciting and transformative new applications, such as digital twins, a reality.